Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. - Test2 - elhamkhani - TriplyDB

Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

http://www.wikidata.org/entity/Q33865096

about

Visceral adiposity syndrome An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium Channels HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis Modulation of glucose metabolism by the renin-angiotensin-aldosterone system A Cross-Sectional Study of the Prevalence of Metabolic Syndrome among Young Female Emirati Adults Disentangling genetic and environmental risk factors for individual diseases from multiplex comorbidity networks The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study Endocrine disrupting chemicals in mixture and obesity, diabetes and related metabolic disorders.Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.Potential biomarker of metformin action.β1-adrenergic receptor stimulation by agonist Compound 49b restores insulin receptor signal transduction in vivo.Decoding insulin resistance and metabolic syndrome for promising therapeutic intervention.Cardiometabolic risk profiles associated with chronic complications in overweight and obese type 2 diabetes patients in South China.Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case-control studies.Modulation of endothelial cell migration by ER stress and insulin resistance: a role during maternal obesity?Tissue-specific insulin signaling in the regulation of metabolism and aging.Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hormones of energy balance in a TCDD-sensitive and a TCDD-resistant rat strain.Approach to assessing determinants of glucose homeostasis in the conscious mouse Pathophysiological roles of cytokine-chemokine immune network.Arsenic induces diabetic effects through beta-cell dysfunction and increased gluconeogenesis in mice Hypochlorous acid via peroxynitrite activates protein kinase Cθ and insulin resistance in adipocytes.Maintenance of homeostasis in the aging hypothalamus: the central and peripheral roles of succinate.Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation Developmental regulation of key gluconeogenic molecules in nonhuman primates Metabolic syndrome in hypertensive adults from rural Northeast China: an update.An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis The VASP Road to NAFLD: A Macrophage Detour Association of thyroid hormones with obesity and metabolic syndrome in Japanese children.Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population.The Role of PTP1B O-GlcNAcylation in Hepatic Insulin Resistance Association of Metabolic Syndrome with the Adiponectin to Homeostasis Model Assessment of Insulin Resistance Ratio.(-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice Serum IGFBP7 levels associate with insulin resistance and the risk of metabolic syndrome in a Chinese population.Vitamin E and vitamin C do not reduce insulin sensitivity but inhibit mitochondrial protein expression in exercising obese rats.Dietary soy and meat proteins induce distinct physiological and gene expression changes in rats De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose Cross-Tissue Regulatory Gene Networks in Coronary Artery Disease Inverse Relationship of the CMKLR1 Relative Expression and Chemerin Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin Resistance.

P2860

Q26738890-7C42F89D-971F-45F5-B615-2CFA04790650 Q26740006-FA5E2877-5348-4E4B-B1F6-C643239D2AAA Q26751133-E61D99B1-85D2-4F36-8885-51DE19D65110 Q26996778-0C26D94A-14E7-4B02-B1CE-A97B08B82559 Q27026157-AB92E43E-55B3-4EAE-9DB0-4E94F0B5EAE3 Q28552609-FD20EF0A-D949-422B-B8D4-93F96816B8B9 Q28584661-0C06421C-FA95-4BC5-83A1-ACC17B1CC093 Q30378222-F400FFA9-3E4A-49CB-927E-DA3FBB945823 Q30402800-05CDF76E-0DA5-4840-BF5C-1084E62AA426 Q33675285-0D8F5CCC-E3AB-45A0-AD0F-C1974363D04F Q33686430-5C5A0002-4728-40BC-878E-36EEDCAE5675 Q33793115-D7D7DCEB-0683-4966-9B80-DBF4C5D62BA7 Q33797567-E91A4071-389B-476D-92CE-0247D0F00CE6 Q33845423-B267462A-9528-4D59-98A4-86FA76D6D45F Q33928280-2EF8D269-6F08-4232-8E86-F1998F08FFEA Q34063250-22AD9B9F-F5C1-4374-A82C-736027309493 Q34076176-26BB7AA2-4657-4F9F-AEA4-7A757ED722F2 Q34158496-7D7AB21B-72B7-41E3-89ED-E63DF973E000 Q34205173-B5A8CAFA-1658-43D6-9C06-229D7FA86155 Q34269772-59B17E3E-36F1-42A3-BFEA-7BC59FCAFDAF Q34447553-01F90C7E-72ED-462E-AEA1-721145289812 Q34665300-134330EC-578D-404A-9F0C-A583C3463BEE Q35037771-6748B4B0-39FA-4577-A0EB-6CAC2DA73370 Q35073075-96BD9AA8-C86D-41BC-8719-2D21CDAF138F Q35094215-283DE312-33D6-47D6-B289-CDED5DB203C8 Q35200909-2FF4ED39-B144-4DE0-82C8-785236AA0337 Q35213260-FAB3A153-B1D3-43A1-A069-5425799C235D Q35667354-B5031CFD-4461-478C-B404-90390F52EC6E Q35881766-6D1FFC53-AD17-4FB8-B550-4F82E3F16B90 Q36049100-0D475486-C503-49B7-B429-60B9D7574DAA Q36109894-7EBD2FE7-B0F7-4A5C-A698-3A7AA378ABB4 Q36184305-D5F4F8DB-AC42-43F0-A3CA-894D1BA8F70F Q36236163-BEA927E5-2D29-4932-B050-44D2ED9779E0 Q36247485-761EA7DF-91E6-484F-88A5-011F1FE15C76 Q36294020-AA34615A-DFA9-4F49-9A7A-C7BFDA9EB1A7 Q36463561-28D1C016-672F-425C-97EA-95871F2424CD Q36559827-4442049B-1907-4550-BB74-CCA26ECEBD25 Q36800168-5387C87E-5678-49E0-A6BC-278B41BE65F4 Q36865220-03A18F6A-A171-4AF6-99BF-D3F81D2AA827 Q36893067-60D354CB-50D9-481F-8BCE-C9958101D351

P2860

Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

http://www.wikidata.org/entity/Q33865096

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Insulin signaling, resistance, ...... odels into disease mechanisms.

@ast

Insulin signaling, resistance, ...... odels into disease mechanisms.

@en

type

label

Insulin signaling, resistance, ...... odels into disease mechanisms.

@ast

Insulin signaling, resistance, ...... odels into disease mechanisms.

@en

prefLabel

Insulin signaling, resistance, ...... odels into disease mechanisms.

@ast

Insulin signaling, resistance, ...... odels into disease mechanisms.

@en

P1433

Q33865096-2906DE4D-F3F9-484B-87E5-792770CF7053

P1476

Q33865096-7839A882-D981-4655-9736-40F855715D0F

P2093

Q33865096-CEB1D2E1-FDAE-410C-8DA0-403B6F3F5613

P2860

Q33865096-01C76447-8B13-4F07-9864-F34A8D447DC5

Q33865096-024DF694-E476-4270-8E5D-FD05CB2B0912

Q33865096-033A3583-F59D-4A5B-9342-57FF47C416D6

Q33865096-04AD03F5-27C0-4120-B308-52192DA2E280

Q33865096-0667442F-6416-4E0F-BD97-D76880A95020

Q33865096-07E4AE91-7E2D-47AA-88D3-A7F03FD0C7C0

Q33865096-0841F773-2104-4C4C-8B21-A990CAE077A2

Q33865096-08909467-DFBC-4D87-832F-3984B66A5BFA

Q33865096-09866B2C-DA2A-40C8-B4C8-617E27E76303

Q33865096-0C11CBCD-E9DC-4352-8DE0-94272B81B765

P304

Q33865096-35CA2A0F-41DA-4015-B83C-902DD74F99BB

P31

Q33865096-FE5F1C79-363F-44A0-B955-73A516043EA7

P356

Q33865096-D8760AAD-4C35-42FC-B4AE-435FF9C274BA

P407

Q33865096-E8B9080F-BB80-4C8D-A2FC-C17B789FE0D4

P433

Q33865096-360F795A-C0B8-4006-870D-347AF79C4463

P478

Q33865096-CE8B4AE6-676E-4C0A-AC97-A497AD0F85E0

P577

Q33865096-72F0CB72-EB81-4240-A929-3B513D33CC10

P698

Q33865096-EA710C71-69B2-4901-990E-BA4FB6349E5D

P921

Q33865096-2838AF1D-CC71-4B8D-B9F9-B5994A2EE789

P932

Q33865096-E6D926C9-8949-4198-9430-1F2FCBFF89EC

P356

P1433

Journal of Endocrinology

P1476

Insulin signaling, resistance, ...... odels into disease mechanisms.

@en

P2093

Shaodong Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Immunoassay of endogenous plasma insulin in man

Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting

The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site

Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription

Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding

Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins

P304

T1-T23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/JOE-13-0327

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

220

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24281010

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

4087161

http://www.w3.org/2001/XMLSchema#string